AMBI Supports Skin of Color Society Research Award

              AMBI Supports Skin of Color Society Research Award

Brand donates $15,000 to fund grant program for skin of color dermatological

PR Newswire

MIAMI BEACH, Fla., March 1, 2013

MIAMI BEACH, Fla., March 1, 2013 /PRNewswire/ -- AMBI® Skincare is pleased to
announce the annual AMBI Research Award with The Skin of Color Society, a
grant of $15,000 to promote dermatology research within the field of skin of
color. By providing essential funding to this program, AMBI and the Skin of
Color Society are helping to shape the future of tomorrow's clinical leaders
in dermatology, expressly in this specialized field. 

The grant addresses the issues specific to skin of color where further
clinical and basic research is needed. The grant will assist a young
dermatologist, a resident or within five years of graduation, in furthering
his or her academic career. Requirements include a strong commitment to
research with a focus that can include hyperpigmentation, anti-aging,
scarring/stretch-marks, photo-protection, skin dryness or acne. Financial need
will be taken into consideration as well.

This annual award is made possible by a generous grant from Valeant
Pharmaceuticals, makers of AMBI Skincare Products, in the amount of $15,000.
"AMBI is dedicated to delivering scientifically proven solutions that address
unique skincare needs, recognizing and celebrating the strength and beauty of
women of color," said Alissa Hsu Lynch of Valeant Pharmaceuticals. "This grant
takes our mission a step further and supports the dermatologists in this field
of inquiry."

Dr. Valerie Callender, President of the Skin of Color Society and Board
Certified Dermatologist, is known for her expertise in hyperpigmentation.
"AMBI's longstanding commitment to the organization and to dermatological
issues primarily affecting skin of color is reflected in this generous
donation," said Dr. Callender. "The program fills a void in the industry where
further study in these specialized topics is crucial. We are proud to partner
with a brand that is devoted to these issues and appreciate the support
they've pledged."

On February 28^th, the grant award recipient, Jenna O'Neill, MD, was announced
at the Skin of Color Society Reception at Loews Miami Beach Hotel in Miami
Beach, FL. Among the 60 attendees, AMBI and Valeant Pharmaceuticals
representatives were on hand to honor Ms. O'Neill for her contribution to
dermatological research in skin of color, specifically in characterizing the
genetic basis of central centrifugal cicatricial alopecia. For more
information on AMBI and Valeant Pharmaceuticals, please visit:

About AMBI^® Skincare
AMBI^® Skincare is one of the brands under Valeant Pharmaceuticals North
America. AMBI, a trusted name in cleansers and moisturizers for skin of color,
has a legacy of skin care designed to provide smooth, even-toned,
flawless-looking skin. Introduced in 1966, the brand has been used and trusted
by women with richer skin tones for decades to provide quality products that
meet skin of color needs. The AMBI® Brand is best known for its fade creams,
which help fade dark spots and skin discolorations to restore flawless,
natural skin tone. The brand is part of the Valeant portfolio that also
includes Kinerase, AcneFree, CeraVe and more.

About Valeant Pharmaceuticals International, Inc.
Valeant Consumer Products, a division of Valeant Pharmaceuticals North America
LLC, (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that
develops, manufactures and markets a broad range of pharmaceutical products
primarily in the areas of neurology, dermatology and branded generics. More
information about Valeant Pharmaceuticals International, Inc. can be found at


Contact: Carolanne Coviello,, Creative Media Marketing,
Press spacebar to pause and continue. Press esc to stop.